Ibrutinib for the Prevention of Chronic Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
Clinical trial NCT06271616 · TERMINATED
Trial details
- NCT number
- NCT06271616
- Sponsor
- Mayo Clinic
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-13
- Primary completion
- 2026-05-14
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.